Treatment of insomnia in elderly patients with headaches

V. A. Golovacheva,A. A. Golovacheva
DOI: https://doi.org/10.21518/ms2023-411
2023-11-23
Meditsinskiy sovet = Medical Council
Abstract:The article describes clinical cases of elderly patients with primary headaches and insomnia managed in neurological practice. The first clinical case provides details of the typical medical history of a female patient with acute insomnia and episodic tension-type headache, the second one describes the typical medical history of a patient with chronic insomnia and chronic migraine. Clinical examples demonstrate common errors in the management of patients with insomnia and primary headaches in real-life medical practice. The influence of psychosocial (stress, anxiety, negative misconceptions about the disease, dysfunctional behaviour, symptom catastrophizing) and iatrogenic (ordering excessive additional diagnostic tests, over-diagnosing of detected structural changes in the spine, neck vessels, brain, diagnostic errors, prescribing of ineffective treatment) factors on the development of insomnia and increase of headaches in frequency is shown. The features of the presented clinical cases are to demonstrate the relationship between insomnia and increased frequency of primary headaches. Patients were treated using the interdisciplinary program comprising non-drug treatments and drug therapy. It has been shown that the treatment of insomnia can not only improve the quality of sleep, but also reduce the frequency of headaches. SonNorm Duo containing melatonin, motherwort extract and peppermint leaf oil was used as a drug therapy for acute and chronic insomnia. Melatonin and substances of plant origin have a high level of effectiveness in the treatment of insomnia and are recommended as drugs to be used first to treat insomnia. The drug therapy of acute and chronic insomnia was combined with highly effective non-drug treatments: an educational program to improve sleep hygiene, cognitive behavioural therapy, and relaxation exercises. During treatment, patients reported an improvement in their sleep quality as early as in the first month. A stable normalization of sleep and a significant decrease in headache frequency in a patient with acute insomnia and episodic tension-type headache occurred after the fifth week of treatment and in a patient with chronic insomnia and chronic migraine after the second month of treatment. A 12-month follow-up of patients showed that the positive effect of the treatment was maintained.
What problem does this paper attempt to address?